Boots welcomes job applications from LloydsPharmacy staff


Share post:

Boots has welcomed job applications from LloydsPharmacy staff impacted by the news of closure of all its branches located in Sainsbury’s before the end of 2023.

The company is recruiting for more than 1,500 pharmacy roles nationwide. Vacancies span pharmacy roles at all levels – from Pharmacy Advisors (Dispensers) and Trainee Pharmacists to experienced Pharmacists looking to develop their careers.

Sebastian James, Managing Director of Boots UK & ROI, said: “Pharmacies deliver vital healthcare in the heart of communities. News of the closure of LloydsPharmacy branches within Sainsbury’s stores will no doubt have an impact on many talented pharmacists as well as their patients.

“We have many roles available at Boots and welcome applications from LloydsPharmacy employees affected by the closures. Patients who are worried about their future pharmacy provision can check our store locator online to find out where their nearest Boots store is – our pharmacy team members are ready to help.”

There are over 2,200 Boots stores across the UK and 85% of the population live within 10 minutes of a Boots store.

In addition to a competitive salary and discretionary bonus scheme, Boots provides a comprehensive range of benefits to team members. These include access to the Boots Retirement Savings Plan pension scheme, a generous staff discount with enhanced savings on Boots own brand products and services and enhanced maternity, paternity and adoption leave pay.

Boots also offers a range of professional development opportunities in clinical services, including the chance to become one of over 2,200 Macmillan Information Pharmacists or progressing into store management. Earlier this year, Boots announced it would fund training bursaries for pharmacists who want to complete training to become pharmacist independent prescribers. To apply for one of the available pharmacy roles, visit




Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...